A Focus on Supportive Care: Strategies to Improve Nausea and Vomiting in Cancer Patients
Chemotherapy-induced nausea and vomiting (CINV) is a serious problem that can negatively impact a cancer patient’s quality of life and affect the timely deliver and ability to give the most effective doses of the chemotherapy treatment.
This activity is designed for oncology healthcare providers (oncologists, oncology nurses, and oncology physician assistants) who care for patients with CINV. No prerequisites required.
After participating in this activity, the participant will demonstrate the ability to:
- RECOGNIZE the impact untreated CINV has on chemotherapy adherence and overall patient outcomes.
- ASSESS patient-specific and therapy-specific CINV risk factors.
- IDENTIFY current and emerging antiemetics used as single agents or in combination therapy for CINV.
- APPLY evidence-based strategies to prevent and manage CINV in patients receiving moderately or highly emetogenic chemotherapy regimens
Susan Urba, MD
Professor of Internal Medicine
Division of Hematology/Oncology
Medical Director, Symptom Management and Supportive Care Program
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
- 0.50 ANCC